Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release. As Healio previously reported, ...

1Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 2Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE ...

Eric Forrest, best known for his time with Voivod and his ongoing work fronting E-Force, has gone public with his battle against prostate cancer. Earlier today, the Toulouse, France–based vocalist and ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...

Prostate cancer burden in 2026 is high, with disproportionate incidence and mortality in Black men and major survival decrements in distant-stage disease, supporting equitable, stage-shifting ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to ...

More than 70% of patients with biochemically recurrent prostate cancer remained metastasis-free 5 years after PSMA PET/CT-guided salvage radiation therapy. Whole-pelvis radiation significantly ...

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...